Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury
Open Access
- 23 April 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (17), 4101-4109
- https://doi.org/10.1182/blood-2008-12-194258
Abstract
Pregnancy loss and intrauterine growth restriction (IUGR) are serious pregnancy complications, and the triggers and mediators of placental and fetal damage are not completely understood. Using a mouse model of recurrent spontaneous miscarriages (DBA/2-mated CBA/J mice) that shares features with human recurrent miscarriage and fetal growth restriction, we identified tissue factor (TF) as an essential participating factor in placental and fetal injury. We have previously shown that C5a releases antiangiogenic molecule sFlt-1 in monocytes that causes defective placental development and fetal death in DBA/2-mated CBA/J mice. In this study, we found that TF not only activates the coagulation pathway, but it also mediates sFlt-1 release in monocytes causing defective placental development and fetal death. Blockade of TF with a monoclonal antibody inhibited sFlt-1 release, prevented the pathological activation of the coagulation pathway, restored placental blood flow, prevented placental oxidative stress, and rescued pregnancies. We also demonstrated that pravastatin, by down-regulating TF expression on monocytes and trophoblasts, prevented placental damage and protected pregnancies in DBA/2-mated CBA/J mice. These studies indicate that TF is an important mediator in fetal death and growth restriction and that statins may be a good treatment for women with recurrent miscarriages and IUGR.Keywords
This publication has 51 references indexed in Scilit:
- Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndromeJCI Insight, 2008
- Tissue factor and its natural inhibitor in pre-eclampsia and SGAThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitorThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody–induced fetal injuryBlood, 2007
- Angiogenesis in implantationJournal of Assisted Reproduction and Genetics, 2007
- Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for PreeclampsiaThe American Journal of Pathology, 2007
- Tumor necrosis factor-α and oxidant status are essential participating factors in unexplained recurrent spontaneous abortionscclm, 2007
- Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restrictionThe Journal of Experimental Medicine, 2006
- Thrombosis during pregnancy and the postpartum periodAmerican Journal of Obstetrics and Gynecology, 2005
- The Emerging Role of Immunoregulation of Fibrinogen‐Related Procoagulant Fgl2 in the Success or Spontaneous Abortion of Early Pregnancy in Mice and HumansAmerican Journal of Reproductive Immunology, 1999